CLEC20A

Model summary

A secreted human lectin-like scaffold that operates outside the cell to organize adhesion and signaling assemblies. By using tandem lectin-like domains, it binds with high avidity to extracellular matrix components and cell-surface receptors, stabilizing multiprotein complexes that fine-tune immune signaling. Its matrix association and packaging into extracellular vesicles position it as a modulatory hub that shapes inflammatory and adaptive responses in the extracellular milieu.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The N-terminal half contains IPR001304 (C-type lectin-like domain, residues 11–131) embedded within two overlapping superfamily signatures, IPR016186 (C-type lectin-like/link domain superfamily, residues 12–134) and IPR016187 (C-type lectin fold, residues 26–134). This defines a canonical C-type lectin-like domain (CTLD) that typically forms a compact β-sandwich fold used for avid, often calcium-independent, binding to glycosylated ligands and to protein partners. A second CTLD module is present in the C-terminal region: IPR001304 (C-type lectin-like domain, residues 151–275) nested within IPR016186 (C-type lectin-like/link domain superfamily, residues 149–279) and IPR016187 (C-type lectin fold, residues 163–278). The tandem arrangement—an N-terminal CTLD followed by a C-terminal CTLD—creates a bivalent extracellular binding platform. Such paired CTLD architectures cause high-avidity interactions with extracellular matrix components and cell-surface receptors, favoring multivalent adhesion and immune-modulatory binding rather than enzymatic catalysis.

2. 02

   This CTLD tandem dictates molecular function as multivalent protein binding (GO:0005515).

   CTLDs frequently mediate homotypic and heterotypic adhesion by recognizing glycoproteins and matrix modules; the presence of two CTLDs increases ligand range and stabilizes complexes. The absence of catalytic motifs and the dominance of adhesion/binding folds reinforce a non-enzymatic, scaffolding role.

3. 03

   From this binding capacity, the biological process follows.

   Extracellular lectin-like scaffolds that cluster receptors and matrix components typically tune innate and adaptive signaling thresholds. By concentrating and stabilizing immune complexes and modulating receptor accessibility, this architecture supports and regulates the immune response (GO:0006955). The dual CTLD layout enables simultaneous engagement of matrix and cell-surface targets, which in turn modulates cytokine presentation, leukocyte adhesion, and antigen-presentation landscapes.

4. 04

   Cellular context is resolved by secretion and matrix association.

   The protein is secreted and detected in the extracellular matrix (GO:0031012), consistent with a soluble matrix-associated lectin-like scaffold. Its presence in extracellular exosomes (GO:0070062) indicates packaging into vesicles that traffic adhesion and signaling modules between cells. Together, secretion and exosomal routing position the protein as an extracellular organizer that bridges matrix and receptor surfaces.

5. 05

   Mechanistically, I hypothesize that the tandem CTLDs drive avid binding to glycosaminoglycan-rich matrix and to cell-surface receptors, forming higher-order assemblies that dampen or potentiate immune signaling depending on context.

   Likely partners include extracellular matrix proteins (e.g., fibronectin and laminins), cell-adhesion receptors (integrins), and immune-modulatory receptors (such as scavenger or lectin receptors). Exosome association suggests transient interactions with tetraspanins and cargo-sorting machinery, enabling spatial delivery of this scaffold to inflamed tissues where it fine-tunes immune responses.